tiprankstipranks
Endonovo Therapeutics, Inc. (ENDV)
:ENDV
US Market
Holding ENDV?
Track your performance easily

Endonovo Therapeutics (ENDV) Financial Statements

22 Followers

Endonovo Therapeutics Financial Overview

Endonovo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.009; its P/E ratio is ―; Endonovo Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.52K$ 45.20K$ 87.54K$ 121.46K$ 10.96K
Gross Profit$ 693.00$ 45.20K$ 83.54K$ 116.60K$ 6.93K
EBIT$ -480.28K$ 2.38M$ 7.54M$ -12.62M$ -264.79K
EBITDA$ -318.55K$ 2.54M$ 7.70M$ -12.44M$ -103.06K
Net Income Common Stockholders$ -766.17K$ 2.06M$ 7.23M$ -12.93M$ -603.36K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ ―$ 32.60K$ 10.94K$ 98.00$ 23.14K
Total Assets$ 815.76K$ 1.01M$ 1.20M$ 1.28M$ 1.45M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 23.78M$ 23.22M$ 25.57M$ 33.46M$ 21.06M
Stockholders Equity$ -22.96M$ -22.20M$ -24.37M$ -32.18M$ -19.61M
Cash Flow-
Free Cash Flow$ -100.00K$ -165.84K$ -173.16K$ -200.00K$ -123.86K
Operating Cash Flow$ -100.00K$ -165.84K$ -173.16K$ -200.00K$ -123.86K
Investing Cash Flow-----
Financing Cash Flow$ 32.77K$ 187.50K$ 184.00K$ 202.50K$ 147.00K
Currency in USD

Endonovo Therapeutics Earnings and Revenue History

Endonovo Therapeutics Debt to Assets

Endonovo Therapeutics Cash Flow

Endonovo Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis